Project Manager, Clinical Trial: Anxiety in Young People
Shelley Baird is a Project Manager with the Youth Mental Health team. She is currently working on two projects alongside Orygen. The CanARY study (Cannabidiol for At Risk Youth) is a clinical trial examining whether cannabidiol (CBD) can reduce symptoms in young people with a heightened risk for psychosis. The second study is looking at whether cannabidiol (CBD) can reduce symptoms in young people with anxiety. Shelley previously worked on the INTEGRATE study, trialling a psychosocial intervention for young people with co-occurring mental health concerns and substance use. Other studies Shelley has worked on include the STEP study (Staged Treatment in Early Psychosis), the YoDA-A study (Youth Depression Alleviation with Anti-inflammatory Agents) and the YoDA – C study (The addition of fluoxetine to cognitive behavioural therapy for youth depression).
Shelley’s research interests are focused on early detection and intervention for mental health problems in adolescents and young adults.
Shelley holds a Bachelor of Nursing from the University of South Australia, as well as a Bachelor of Psychology at Murdoch University.